ABSTRACT Hens were vaccinated during the rearing phase with infectious bronchitis virus (IBV) vaccines commercially available in Australia (Vic S and A3) or left unvaccinated and then challenged with the N1/88 strain of IBV at 30 wk of age. Oviduct and fecal samples were collected at regular intervals after N1/88 challenge. A locked nucleic acid probe-based reverse transcription real-time PCR test was designed and used to detect the IBV strain N1/88 from the oviduct and feces of unvaccinated and vaccinated laying hens. Using a recombinant plasmid standard, the detection limit of the reaction was found to be 100 copies and independent assay runs showed reproducible threshold cycle values. Viral RNA was detected in the oviduct of 12 unvaccinated then challenged hens and viral RNA increased sharply on d 10 and 12 postinfection (p.i.). By contrast, among the hens in the vaccinated group, N1/88 was detectable only in the oviduct of 2 hens at 8 and 12 d p.i. N1/88 challenge. Viral RNA was detected in feces of 2 unvaccinated hens up to 4 wk p.i. and in 1 vaccinated hen up to 3 wk p.i. This shows that rearing phase vaccination lowers the total viral RNA of the strain N1/88, even though this strain shows considerable antigenic and genetic variation from the vaccine strain. This new test will be useful for the rapid identification of the N1/88 strain of IBV from oviduct and fecal samples.
INTRODUCTION
Infectious bronchitis virus (IBV) causes acute, highly contagious respiratory and urogenital disease of chickens, which results in significant economic losses in the poultry industry. In layers, American strains of IBV can cause severe declines in egg production and also deterioration in eggshell quality and egg internal quality (Sevoian and Levine, 1957) . Such effects may be accompanied by mild (Muneer et al., 1987) or no respiratory signs (Cook and Huggins, 1986) . Various vaccines and protocols to control this viral disease have been developed, although the severity of this disease varies from place to place and flock to flock. All of the laying hens in Australia are currently vaccinated against IBV. In the Australian layer industry, the approach commonly used for IBV vaccination is to vaccinate the flock using live attenuated vaccines (Vic S and in some cases also A3) during the rearing phase. Some producers vaccinate their flocks with live attenuated vaccine Vic S periodically during lay; however, this approach can cause deterioration of eggshell quality (Sulaiman et al., 2004) . Vaccine strain A3 was developed from the field strain N2/62 isolated in Armidale, New South Wales, in 1962, which was passaged 25 times. The Vic S vaccine was developed after the 20th passage in chicken embryos of a strain isolated in Victoria (Ratanasethakul and Cumming, 1983 ). Both vaccine strains, A3 and Vic S, can multiply in the oviduct without causing oviduct pathology (Chousalkar et al., 2009a) . The pathogenic N1/88 strain of IBV, which was isolated from a vaccinated broiler flock, has a primary tropism for the respiratory tract (Sapats et al., 1996a) and can cause oviduct damage . The N1/88 and vaccine strains (A3 and Vic S) have been placed into 2 different groups based on the variation in their antigenicity (Ignjatovic and McWaters, 1991) and nucleocapsid gene sequence (Sapats et al., 1996b) . Although there is continuous evolution of the virus, vaccination is the only reliable way to prevent production losses. The frequency of isolation varies with the time frame, but Alexander and Gough (1977) isolated virus from cecal tonsils and feces up to 14 and 20 wk, respectively. Jones and Ambali (1987) isolated the G strain of IBV up to 28 wk of age in tracheal and cloacal swabs from birds infected at 1 d of age. Currently, reverse transcription PCR (RT-PCR) is commonly used for diagnosis of IBV. Using RT-PCR, IBV has been detected directly from clinical samples such as the trachea, kidney, or cloacal swabs (Mardani et al., 2008) . The aim of the present study was to detect the N1/88 viral RNA from the oviduct and feces of N1/88-challenged, vaccinated, and unvaccinated laying hens using the locked nucleic acid (LNA) probe-based real-time PCR assay.
MATERIALS AND METHODS

Bird Experiment
One-day-old pullets (n = 160) were obtained from a commercial hatchery. At 1 d of age, all birds received Rispens vaccine against Marek's disease but no other vaccinations at the hatchery. The chickens were raised in isolation houses at the University of New England. The birds were randomly divided into 2 groups and placed in separate isolation houses. Half of the birds were vaccinated with Vic S on d 1 by the intraocular route at the dose rate of 10 4.5 50% embryo infective dose (EID 50 ). At 4 wk of age, these same birds were vaccinated intraocularly with A3 at the dose rate of 10 3.9 EID 50 . At 12 wk of age, these birds were again vaccinated intraocularly with Vic S at the dose rate of 10 4.5 EID 50 . Vaccines were obtained from Fort Dodge, (Baulkham Hills, Australia), who also provided the titers of the vaccines. All vaccinated birds were reared on the floor in contact with one another. The other half of the birds, which were reared in a separate isolation house, remained unvaccinated. At 25 wk of age, the unvaccinated and vaccinated birds were divided randomly into 4 groups. There were 2 control groups: unvaccinated-unchallenged (UC) with 30 birds, vaccinated-unchallenged (VC) with 30 birds, and 2 treatment groups of 50 birds each: unvaccinated-challenged with N1/88 (N1/88) and vaccinated-challenged with N1/88 (VN1/88). All birds were moved into cages at the age of 25 wk and housed individually. Birds were fed a commercial broiler starter diet to 3 wk of age, chick starter to 5 wk, pullet grower to 16 wk, and commercial layer mash until the end of the experiment. Each treatment group of hens was maintained separately in isolation houses at the University of New England campus (Armidale, Australia). All equipment, facilities, and clothing were fumigated or washed with antiseptic or ethanol before use. Daily egg production was recorded and clinical signs were monitored. All of the hens were bled before the challenge experiment. Plasma samples of unvaccinated hens were negative for IBV antibodies (IDEXX IBV antibody ELISA kit, IDEXX Laboratories, Westbrook, ME; . The experimental protocol was approved by the University of New England Animal Ethics Committee.
Virus Challenge
At 30 wk of age, when all of the hens were at full lay, each hen in the N1/88 and VN1/88 groups was challenged with the N1/88 strain of IBV (obtained from Jagoda Ignjatovic, Commonwealth Scientific and Industrial Research Organisation, Geelong, Australia) at the dose rate of 2 × 10 5 EID 50 intraocularly. Each hen in the control groups of birds (UC and VC) was sham-inoculated with normal saline. Two hens from each challenge group (N1/88 and VN1/88) and 1 hen from each control group (UC and VC) were killed at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 d postinfection (p.i.) . The oviducts of all killed hens were examined macroscopically and collected aseptically. Feces were collected in individual sterile plastic containers from 5 hens from each group at weekly intervals from 1 to 9 wk post infection.
RNA Extraction from Allantoic Fluid
Extraction and purification of RNA was conducted according to the manufacturer's instructions using an RNA easy kit (Qiagen, Hilden, Germany; Chousalkar et al., 2009b) with some modifications. Allantoic fluid (400 μL) was mixed with 300 μL of RNA easy tissue lysis buffer. Five microliters of mercaptoethanol was then added. This mixture was vortexed and kept at room temperature for 10 min. After incubation at room temperature, 700 μL of 70% ethanol was added, and the solution was transferred to a spin column in 2 steps. Washing and elution were performed according to the manufacturer's instructions. The elution volume was 30 μL. Extracted RNA was quantified and stored at −70°C until used for PCR. Samples were kept at 4°C throughout the extraction to avoid degradation of the RNA.
Viral RNA Extraction from the Oviduct
Extraction and purification of RNA was conducted according to the manufacturer's instructions using an RNA easy kit (Qiagen) with some modifications. The luminal surface of the entire oviduct tissue was scraped with a sterile scalpel blade. The scraping was mixed with 400 μL of RNA easy tissue lysis buffer buffer. Five microliters of mercaptoethanol was then added. This mixture was vortexed and kept at room temperature for 10 min. The samples were homogenized and lysate was centrifuged at 8,000 × g for 3 min. The supernatant was carefully removed and 400 μL of 70% ethanol was added. The solution was transferred to a spin column. Washing and elution were performed according to the manufacturer's instructions. The elution volume was 30 μL. Extracted RNA was quantified using a spectrophotometer (Nanodrop ND 1000, Wilmington, DE) and stored at −70°C before use for real-time RT-PCR. All of the oviduct samples were analyzed in duplicate during each reaction. Fifty nanograms of oviduct tissue RNA was used in each reaction. Viral RNA from A3 and Vic S known positive samples was also tested using primers and a LNA probe designed for N1/88 detection. This assay was used to determine the total viral RNA extracted from 72 oviduct samples.
Viral RNA Extraction from Feces
Ribonucleic acid from feces was extracted as described previously by Culver et al. (2008) using a QIAamp DNA stool mini kit (Qiagen) with some modifications. Fecal samples (0.2 g), collected from 1 to 9 wk p.i. from 5 hens of each group were weighed and dispensed into microcentrifuge tubes containing 2 mL of Aamp stool lysis buffer. The samples were vortexed and heated in a 70°C water bath for 5 min. The samples were centrifuged at 4,800 × g for 10 min and 120 μL of the supernatant was transferred to another clean microcentrifuge tube containing an Inhibitex tablet (Qiagen). The samples were vortexed and stored at room temperature for 1 min. The samples were then centrifuged at 4,800 × g for 10 min and 200 μL of the resulting supernatant was treated with 15 μL of proteinase K and 200 μL of Aamp lysis buffer. The mixture was reheated at 70°C and transferred to a spin column. Washing and elution was performed according to the manufacturer's instructions. The elution volume was 100 μL. Extracted RNA was quantified using a spectrophotometer (Nanodrop ND 1000) and stored at −70°C until used for real-time RT-PCR. Fifty nanograms of fecal RNA was used during the real-time PCR reaction.
Development of Plasmid Constructs for Real-Time PCR
A 123-bp fragment of the nucleocapsid region of the N1/88 strain of IBV was amplified by standard RT-PCR using the primer pair described in Table 1 and a 1-step RT-PCR kit (Qiagen) according to the manufacturer's instructions. The PCR product was purified using a Wizard DNA purification kit (Promega, Madison, WI). This fragment was cloned into pGEM-T-Easy (Promega) and sequenced as described earlier (Chousalkar et al., 2009b) . Plasmid DNA was extracted and purified from a 10-mL culture of transfected Escherichia coli using a Wizard Plus Miniprep DNA purification kit (Promega) according to the manufacturer's instructions. The DNA sequence of the plasmid insert was determined at Macquarie University (Sydney, Australia). The concentration of plasmid DNA was determined by agarose gel electrophoresis using 2-, 4-, and 8-fold dilutions against a lambda DNA standard. Plasmid copy number was then calculated based on the concentration of plasmid DNA and its molecular weight.
Primer and LNA Probe Set for Real-Time RT-PCR
Nucleocapsid gene sequences from the N1/88, A3, and Vic S strains of IBV were retrieved from GenBank accession numbers U52599, DQ490205, and U52594 (Sapats et al., 1996b; Mardani et al., 2008) . All of the sequences were aligned using Clustal W2 (EBI sequence analysis tool, Cambridge, UK). The sequence alignment indicated that the nucleocapsid gene sequences of A3 and Vic S exhibited difference from N1/88. The primers and probe required for the real-time RT-PCR were generated within a 123-bp region of the N1/88 nucleocapsid gene. The details regarding primers and LNA probe (labeled with FAM and BHQ) are given in Table  1 . The primers were manufactured by Geneworks (Adelaide, Australia) and the LNA probe was synthesized by Exiqon (Vedbaek, Denmark).
Standard Curve
A series of 10-fold dilutions of plasmid DNA, starting from 1 × 10 6 to 1 × 10 0 , were used to identify the threshold of detection. The reproducibility of the reaction was determined by 3 independent assays using the plasmid standard. Each individual assay was performed on different days using freshly diluted standard. The interassay CV was calculated by comparing the mean of the threshold cycle (Ct) of 3 separate but identical assays.
Real-Time RT-PCR Protocol
The LNA probe-based real-time RT-PCR was performed using a Rotor Gene 3000 real-time PCR instrument (Corbett Research, Sydney, Australia) and a 1-step RT-PCR kit (Invitrogen Australia Pty Limited, Victoria). Each reaction contained 10 μmol of each primer and probe, 12.5 μL of quantitative PCR supermix, and 5 μL of RNA template in a total reaction volume of 25 μL. Duplicate reactions were run for each sample. The cycling parameters were 50°C for 15 min then 95°C for 2 min followed by 45 cycles at 95°C for 15 s followed by 64°C for 30s. Raw data were analyzed using the default settings of the software for determination of base line and threshold of the reaction. The test sensitivity was determined by running 10-fold serial dilutions of the plasmid DNA with known copy numbers. Viral RNA extracted from stock virus (allantoic fluid) was used to validate the reaction and was also used as a positive control.
RESULTS
Real-Time PCR Assay Sensitivity and Specificity
A 123-bp fragment of the nucleocapsid region of the N1/88 strain of IBV was amplified using non-quantitative RT-PCR (standard RT-PCR). The fragment was cloned into the pGEM-T Easy vector (Promega) to generate the plasmid standard. The detection and quantification limits of the real-time PCR assay were determined by setting up duplicates of 10-fold dilutions of the plasmid molecules ranging from 10 6 to 10 0 . The log-linear standard curve generated from these plots showed high accuracy of the reaction with R 2 = 0.979, y = −3.52 log (x) + 40.32 with various concentrations containing 10 6 to 10 2 copies of the plasmid DNA. There was no significant difference (P > 0.05) between mean Ct values and mean plasmid copy number of 3 independent assays. The detection limit for RNA was not determined. The assay was negative below 100 DNA copies; hence, this is the limit of detection. The mean intraassay CV based on Ct value was 1.24% and mean interassay CV based on Ct value was 2.45%. The primers and probe designed to detect N1/88 total viral RNA did not give any reaction (no amplification) with viral RNA extracted from samples positive for A3 or Vic S, the 2 vaccine strains.
IBV Strain N1/88 Viral RNA in the Oviduct of Unvaccinated and Vaccinated Hens
The real-time RT-PCR assay was used to determine total N1/88 viral RNA in the oviduct samples from the unvaccinated and vaccinated challenged birds. In unvaccinated N1/88 challenged hens, virus was detected in the oviduct of both hens killed on d 8, 10, and 12 d p.i. Virus was also detected in the oviduct of 1 hen each killed on d 6, 14, 16, 20, and 24 d p.i. Virus was not detectable in any hen at 2, 4, 18, and 22 d p.i. (Table  2 ). In the VN1/88 hens, virus could be detected only in the oviduct of 1 hen each killed on d 8 and 12 p.i. There were no macroscopic lesions in the oviduct of hens from any group.
IBV Strain N1/88 Viral RNA in the Feces of Unvaccinated and Vaccinated Hens
In the N1/88 infected group, virus was detected from the feces of 3 hens in the first 2 wk and 2 hens during the third and fourth weeks. In the VN1/88 group, virus was detected in the feces of 2 hens during the first week and then in 1 hen during the second and third weeks. Virus was not detected in either the unvaccinated or vaccinated group from 5 wk p.i. and onward (Table 3) . The fecal samples of the hens from control groups were negative throughout the experiment.
DISCUSSION
A 123-bp fragment of the nucleocapsid region of the N1/88 strain of IBV matched the sequence published earlier (Sapats et al., 1996b) , indicating that errors were not introduced during RT-PCR. Primers and a probe designed within the nucleocapsid region of the N1/88 strain of IBV did not give a positive reaction to either of the A3 or Vic S vaccine strains. In the present study, we described the development and evaluation of a single-step LNA probe-based real-time RT-PCR for the determination of viral RNA of the N1/88 strain of IBV directly from oviduct and fecal samples of vaccinated and unvaccinated hens. A real-time PCR test has been developed recently using a Taqman probe for the detection of American strains of IBV from tracheal swabs (Callison et al., 2007) and using a LNA probe for the detection of other Australian IBV strains (Chousalkar et al., 2009b) . Sequence analysis suggests that the assays developed earlier (Callison et al., 2007; Chousalkar et al., 2009b) would not detect the viral RNA of the N1/88 strain of IBV used in this study. The N1/88 strain of IBV can induce severe cytopathology in the albumen-forming region of the oviduct and is responsible for runny albumen (watery whites) and deterioration of eggshell quality in terms of eggshell color (Chousalkar and Roberts, 2009 ). The current test will be useful to detect and monitor the spread of the N1/88 strain of IBV among vaccinated laying hens.
No IBV N1/88 was detected in unchallenged control hens, indicating that biosecurity precautions were adequate. The N1/88 viral RNA was detected from the fully functional oviduct of unvaccinated hens from 6 to 24 d p.i. The Massachusetts strain of IBV has been isolated from the oviduct of hens between 5 and 11 d p.i. (Jones and Jordan, 1971) . This is consistent with our earlier ultrastructural findings of the IBV-infected oviduct . However, on d 16 and 20 p.i., pathology was recorded only in terms of lymphocyte infiltration. Our findings suggest that the N1/88 viral RNA appears to peak between 8 to 12 d p.i. in unvaccinated hens. Vaccination at rearing phase reduced the viral RNA of the N1/88 strain to below the detectable levels in the fully functional oviduct of 10 of the 12 vaccinated hens tested between 6 and 16 d p.i., whereas the N1/88 strain of IBV was detectable in 9 out of 12 unvaccinated hens tested between 6 and 16 d p.i.
A strong binding of a probe during annealing is a prerequisite for the sensitive real-time PCR assay, which is obtained by designing probes with 5 to 10°C higher melting temperatures than primers. For Taqman probes, this could result in 25-to 30-nucleotide-long probes. Taqman probes are difficult to design in the case of short specific sequences (Josefsen et al., 2009) . Locked nucleic acid probes, which are short but still have a high melting temperature, are preferred over Taqman probes for amplification of short specific regions of the nucleocapsid gene of the N1/88 strain of IBV. A real-time RT-PCR with high-resolution melt curve analysis has also been developed based on the 3′ untranslated region of IBV for rapid detection and classification of Australian strains of IBV (Hewson et al., 2009) . However, the assay described in the present study is quantitative. There is a dearth of information regarding the estimation of heterologous IBV RNA in the oviduct of vaccinated laying hens, which could be due to the intensive labor required and constraints of maintaining hens under disease-free conditions. An in vitro model to assess the protectivity of IBV vaccine strains was established earlier (Dhinakar Raj and Jones, 1996) ; however, in vivo experiments are the ultimate method to check the safety and efficacy of vaccine strains. The present study suggests that vaccine strains reduce the viral RNA level of a N1/88 strain of IBV, which is genetically and antigenetically different from vaccine strains of IBV (Ignjatovic and McWaters, 1991; Sapats et al., 1996a,b) . In the present study, the finding regarding the reduction of IBV N1/88 viral load in the oviduct is based on a reverse transcription realtime PCR test. However, considering the respiratory and uterotropism of IBV N/88 strain, more comprehensive studies regarding comparative microscopic, egg quality, clinical, and serological findings are essential to establish the protectivity of the vaccine strains against a wild strain challenge. Detection and quantitation of N1/88 of IBV from the feces using real-time PCR assay has not been reported previously. The T strain of IBV was isolated from the fecal samples of T-strain-infected hens up to 225 d p.i. (Alexander and Gough, 1977) . Massachusetts serotype vaccine virus has been isolated also from cloacal swabs at 63 d p.i. (Naqi et al., 2003) . Excretion of virus and its subsequent isolation from feces could be due to the urates present in the feces. Shedding of IBV through feces could be an important means of introducing virus into new premises (Jones and Ambali, 1987) . Based on the real-time PCR results shown above in the report, it could be concluded that the real PCR test designed during this experiment can detect the N1/88 strain of IBV in environmental samples like feces. The current test will also be useful to monitor the spread of the N1/88 strain of IBV among vaccinated chicken populations.
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